Analyst Price Targets — EMA
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 11, 2026 9:40 am | Michael Lonegan | Barclays | $52.00 | $52.60 | TheFly | Emera price target lowered to $52 from $53 at Barclays |
| April 28, 2026 10:12 am | — | Barclays | $53.00 | $52.70 | TheFly | Emera initiated with an Equal Weight at Barclays |
Latest News for EMA
Hansa Biopharma announces first commercial kidney transplant patient treated with Idefirix in Australia PR Newswire
Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced that the European Medicines Agency (EMA) has validated the Marketing
BATON ROUGE, La., Aug. 12, 2026 /PRNewswire/ -- Bernhard Capital Partners ("Bernhard"), an infrastructure and services-focused private markets investment firm, announced today that it has closed on its previously announced acquisition of New Mexico Gas Company ("NMGC") from Emera Inc. ("Emera") (TSX/NYSE: EMA).
HALIFAX, Nova Scotia--(BUSINESS WIRE)--Emera Inc. (TSX/NYSE: EMA) today announced the transaction to sell New Mexico Gas Company (NMGC), a regulated natural gas utility headquartered in Albuquerque, New Mexico, to Bernhard Capital Partners has closed. The sale of NMGC was originally announced on August 5, 2024. About Emera Inc. Emera (TSX/NYSE: EMA) is a leading North American provider of energy services…
Emera TSE: EMA reported second-quarter adjusted earnings of C$212 million, or C$0.69 per share, as the utility advanced asset sales designed to strengthen its balance sheet and concentrate investment on its regulated businesses.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for EMA.
U.S. House Trading
No House trades found for EMA.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.